Clinical Trials Browser

Phase 1/2 × Lymphangioleiomyomatosis × 90 days × Clear all

NCT01799538 2026-03-11

Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis

Phase 1/2 Recruiting

Lymphangioleiomyomatosis

NCT05467397 2026-01-21

Feasibility of [11C]Acetate-PET in LAM and TSC

Phase 1/2 Active not recruiting

7 enrolled 6 charts

Tuberous Sclerosis, Lymphangioleiomyomatosis